ISM Products &
Services
ISM products and services are intended to restore
the natural defense mechanisms of the immune system, with the goal to extend life or, at
minimum, significantly improve quality of life. The compounds target an
individual's own self-healing metabolic and immune system capacity while
avoiding the toxic side effects that often accompany conventional cancer medic al
treatment.
The ISM-Immune System Management® program first guides an individual towards an optimal balance of
all the body’s natural and critical metabolic and biochemical “tools” such
as enzymes, amino acids, vitamins, minerals, antioxidants and fatty acids that are used
directly by the body’s immune & metabolic systems (we refer to this as a
client’s “blueprint” or ISM Profile). Then a disease-specific compound is
administered. The ISM® line of Aminomics products has been
developed from the analysis of consistent patterns amongst similar disease-related
clients who  have undergone client-specific
therapeutic treatment.
Our products and services empower the client to accept responsibility for at least part of the task of
their recovery and health maintenance. The products currently offered
include:
Aminomic® Profiling
Individualized Custom
Analysis and Compounding.
Development of the Aminomics® Product and Protocol
The origins of the ISM® products started with
individual clinical client nutraceutical supplementation. Clinical work with hundreds of
clients over a ten-year period has led to certain common sets of observations concerning
the diagnostic and therapeutic impact of our nutraceutical supplementation hypotheses.
The step-by-step product development process involved:
1) Client-specific statistical analysis where we observed significant biochemical blood
stream discrepancies between healthy clients and clients diagnosed with cancer.
2) Development of an ongoing series of analytical, chromatography-based procedures to
measure these compounds.
3) Definition of the optimal concentration ranges for each compound that should optimally
be present in the bloodstream.
4) Development of algorithms that allow us to predict the composition of an individual
client’s treatment compound.
Science/Medical papers concerning our general therapeutic
hypothesis have been presented at various medical conferences and presentations. Visit the Research section of this website for further information.
The cumulative conclusion of these papers is that:
"Many cancer symptoms correlate with disturbances in the host's protein
metabolism. Normalization of imbalanced plasma amino acid profiles by the administration
of client-specific amino acid formulas can positively influence the clinical management
of the cancer."
The following Nutraceutical Search button will lead you to an ISM® search engine where you can explore the description of many
orthomolecular/nutritional products that are a part of the overall Aminomics® compound.
|
